Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christopher Johnson

Orthopaedic Surgery of the Spine Englewood, CO Medical Doctor

NPI 1164917332 CMS profile 11305760

145 Inverness Dr E Ste 100, Englewood, CO 80112

Open in the dashboard

General payments

$28,788

123 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Johnson of Englewood, CO is reported in the CMS Open Payments database as having received $28,788 across 123 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 62nd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,497 46
2024 General $2,809 22
2023 General $8,959 43
2022 General $1,402 11
2021 General $120 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Johnson
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Christopher Johnson were reported at $15,497. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Christopher Johnson Orthopaedic Surgery of the Spine median Middle half National median
2019 $0 $2,106 $337–$18,608 $163
2020 $0 $1,213 $156–$15,082 $114
2021 $120 $1,834 $271–$15,617 $132
2022 $1,402 $2,015 $320–$17,036 $149
2023 $8,959 $1,925 $336–$14,599 $160
2024 $2,809 $2,110 $341–$12,483 $164
2025 $15,497 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Alphatec Spine, Inc $17,235 63 payments
  2. Kuros Biosciences USA, Inc $6,407 8 payments
  3. Life Spine, Inc. $2,138 13 payments
  4. Stryker Corporation $1,130 9 payments
  5. Medtronic, Inc. $811 9 payments
  6. Seaspine Orthopedics Corporation $299 3 payments
  7. NuVasive, Inc. $248 9 payments
  8. SI-BONE, Inc. $189 2 payments
  9. Baxter Healthcare $137 2 payments
  10. Boston Scientific Corporation $85 2 payments
  11. Other $108 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $12,651 35 payments
  2. Consulting Fee $9,950 2 payments
  3. Food and Beverage $6,187 86 payments
Products named General payments · program years 2021–2025
  1. Other - Miscellaneous $10,532 42 payments
  2. MAGNETOS $6,407 8 payments
  3. ProLift Lateral $1,957 10 payments
  4. ProLift Lateral Helo $1,025 6 payments
  5. CENTRIC - T RETRACTOR $1,025 6 payments
  6. SENTRY LATERAL PLATING SYSTEM $1,025 6 payments
  7. ProLift Lateral Fixated $1,025 6 payments
  8. EVEREST SPINAL SYSTEM $950 7 payments
  9. ProLIft $755 1 payment
  10. MAZOR X SYSTEM $335 5 payments
  11. Other $2,796 42 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

82

Median for Orthopedic Surgery: 203

Drug cost

$635

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 26 $216
Oxycodone Hcl Generic 23 $149
Methylprednisolone Generic 20 $145
Methocarbamol Generic 13 $125

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$93,226

Medicare's payments for the services billed

Medicare patients

135

Average age 73

Services billed

555

77 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 61%
Depression 30%
Ischemic heart disease 26%
Osteoporosis 25%
Cancer 20%
COPD 17%
Diabetes 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

123 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record